PAPER Fernández-Ferreira R, García-Santos RA, Rodríguez-Violante M, López-Martínez C, Becerra-Laparra IK, Torres-Pérez ME
SEARCH RESULTS
15878 RESULTS
PAPER Rojo R, Raper A, Ozdemir DD, Lefevre L, Grabert K, Wollscheid-Lengeling E, Bradford B, Caruso M, Gazova I, Sánchez A, Lisowski ZM, Alves J, Molina-Gonzalez I, Davtyan H, Lodge RJ, Glover JD, Wallace R, Munro DA, David E, Amit I, Miron VE, Priller J, Jenkins SJ, Hardingham GE, Blurton-Jones M, Mabbott NA, Summers KM, Hohenstein P, Hume DA, Pridans C
Deletion of a Csf1r enhancer selectively impacts CSF1R expression and development of tissue macrophage populations.
Nat Commun. 2019 Jul 19;10(1):3215. PubMed: 31324781Can Researchers Detect Dementia With Lewy Bodies at the Prodromal Stage?
CONFERENCE COVERAGE 2019-07-21 Conference Coverage For neurodegenerative disease, the mantra is “go early,” based on the theory that intervention at prodromal stages may be most effective. Early detection could also help patients and families plan for the future, and avoid drugs contra
Yunfeng Zheng on Do Microglia Finish Off Stressed Neurons Before Their Time?
COMMENT Does that mean AD is an autoimmune disease due to hyperactivation of microglia induced by stress? Stress-impaired LTP or facilitated LTD means reduced electrical activity, and that leads to microglia's abnormal attack on silent synapses. zhengyunfeng
Sarah Ben Youssef
Tunis, Tunisia
PAPER Ngoungoure VL, Muñoz P, Tizabi Y, Valdes R, Moundipa PF, Segura-Aguilar J
Protective Effects of Crude Plant Extracts against Aminochrome-induced toxicity in Human Astrocytoma Cells: Implications for Parkinson's Disease.
Clin Pharmacol Transl Med. 2019;3(1):125-133. Epub 2019 Apr 8 PubMed: 31321384PAPER Fujita K, Matsubara T, Miyamoto R, Sumikura H, Takeuchi T, Maruyama Saladini K, Kawarai T, Nodera H, Udaka F, Kume K, Morino H, Kawakami H, Hasegawa M, Kaji R, Murayama S, Izumi Y
Co-morbidity of progressive supranuclear palsy and amyotrophic lateral sclerosis: a clinical-pathological case report.
BMC Neurol. 2019 Jul 18;19(1):168. PubMed: 31319800PAPER Osuagwu N, Dölle C, Tzoulis C
Poly-ADP-ribose assisted protein localization resolves that DJ-1, but not LRRK2 or α-synuclein, is localized to the mitochondrial matrix.
PLoS One. 2019;14(7):e0219909. Epub 2019 Jul 19 PubMed: 31323073PAPER Tsukita K, Sakamaki-Tsukita H, Tanaka K, Suenaga T, Takahashi R
Value of in vivo α-synuclein deposits in Parkinson's disease: A systematic review and meta-analysis.
Mov Disord. 2019 Oct;34(10):1452-1463. Epub 2019 Jul 19 PubMed: 31322768PAPER Loeffler DA, Aasly JO, LeWitt PA, Coffey MP
What Have We Learned from Cerebrospinal Fluid Studies about Biomarkers for Detecting LRRK2 Parkinson's Disease Patients and Healthy Subjects with Parkinson's-Associated LRRK2 Mutations?
J Parkinsons Dis. 2019;9(3):467-488. PubMed: 31322581PAPER Calderón-Garcidueñas L, Kulesza RJ, Mansour Y, Aiello-Mora M, Mukherjee PS, González-González LO
Increased Gain in the Auditory Pathway, Alzheimer's Disease Continuum, and Air Pollution: Peripheral and Central Auditory System Dysfunction Evolves Across Pediatric and Adult Urbanites.
J Alzheimers Dis. 2019;70(4):1275-1286. PubMed: 31322574PAPER Ohlsson B, Englund E
Atrophic Myenteric and Submucosal Neurons Are Observed in Parkinson's Disease.
Parkinsons Dis. 2019;2019:7935820. Epub 2019 Jun 19 PubMed: 31321021PAPER Proctor EA, Mowrey DD, Dokholyan NV
β-Methylamino-L-alanine substitution of serine in SOD1 suggests a direct role in ALS etiology.
PLoS Comput Biol. 2019 Jul;15(7):e1007225. Epub 2019 Jul 19 PubMed: 31323035PAPER Zhao Z, Fu J, Li S, Li Z
Neuroprotective Effects of Genistein in a SOD1-G93A Transgenic Mouse Model of Amyotrophic Lateral Sclerosis.
J Neuroimmune Pharmacol. 2019 Dec;14(4):688-696. Epub 2019 Jul 18 PubMed: 31321663PAPER Watts ME, Wu C, Rubin LL
Suppression of MAP4K4 Signaling Ameliorates Motor Neuron Degeneration in Amyotrophic Lateral Sclerosis-Molecular Studies Toward New Therapeutics.
J Exp Neurosci. 2019;13:1179069519862798. Epub 2019 Jul 10 PubMed: 31320806Current Filters
- Date Range : Jul 2018 to Jul 2019 x